Advertisement
UK markets closed
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • FTSE 250

    20,164.54
    +112.21 (+0.56%)
     
  • AIM

    771.53
    +3.42 (+0.45%)
     
  • GBP/EUR

    1.1652
    -0.0031 (-0.26%)
     
  • GBP/USD

    1.2546
    +0.0013 (+0.11%)
     
  • Bitcoin GBP

    50,305.46
    +110.29 (+0.22%)
     
  • CMC Crypto 200

    1,313.53
    +36.55 (+2.86%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • DOW

    38,675.68
    +450.02 (+1.18%)
     
  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     
  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     
  • DAX

    18,001.60
    +105.10 (+0.59%)
     
  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     

North America Digital Respiratory Solutions Market Report 2020-2030

Dublin, Sept. 01, 2020 (GLOBE NEWSWIRE) -- The "North America Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

The North American digital respiratory solutions market is expected to grow by 34.4% annually in the forecast period and reach $155.05 million by 2030, driven by the rising demand for respiratory aids and air purification amid COVID-19 pandemic.

The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.

Highlighted with 24 tables and 39 figures, this 98-page report is based on a comprehensive research of the entire North America digital respiratory solutions market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain.

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure

  • Growth Drivers

  • Restraints and Challenges

  • Emerging Product Trends & Market Opportunities

  • Porter's Five Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America digital respiratory solutions market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country.

Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Therapeutic Devices

  • Inhalers

  • Nebulizers

ADVERTISEMENT

Diagnostic Devices

  • Spirometers

  • Asthma Monitors

  • Other Diagnostic Devices

Sensors and Apps

Based on Indication, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

  • Asthma

  • Chronic Obstructive Pulmonary Disease (COPD)

  • COVID-19 Caused Diseases

  • Other Diseases

Based on Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmacies

Geographically, the following national/local markets are fully investigated:

  • U.S.

  • Canada

  • Mexico

For each aforementioned country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Indication, and Distribution Channel over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in North America digital respiratory solutions market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players

  • 3M Health Care Limited

  • Adherium Limited

  • Amiko Digital Health Limited

  • AsthmaMD

  • AstraZeneca plc

  • Boehringer Ingelheim International GmbH

  • Capsule Technologies, Inc.

  • Cohero Health

  • GlaxoSmithKline plc

  • Kaia Health Software GmbH

  • Medical International Research (MIR)

  • Novartis AG

  • NuvoAir

  • Reciprocal Labs (Propeller Health)

  • Sensiron AG

  • Tactio Health

  • Teva Pharmaceuticals Industries Ltd.

Key Topics Covered

1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter's Five Forces Analysis

3 Segmentation of North America Market by Product Type
3.1 Market Overview by Product Type
3.2 Therapeutic Devices
3.2.1 Inhalers
3.2.2 Nebulizers
3.3 Diagnostic Devices
3.3.1 Spirometers
3.3.2 Asthma Monitors
3.3.3 Other Diagnostic Devices
3.4 Sensors and Apps

4 Segmentation of North America Market by Indication
4.1 Market Overview by Indication
4.2 Asthma
4.3 Chronic Obstructive Pulmonary Disease (COPD)
4.4 COVID-19 Caused Diseases
4.5 Other Diseases

5 Segmentation of North America Market by Distribution Channel
5.1 Market Overview by Distribution Channel
5.2 Hospital Pharmacies
5.3 Retail Pharmacies
5.4 Online Pharmacies

6 North America Market 2019-2030 by Country
6.1 Overview of North America Market
6.2 U.S.
6.3 Canada
6.4 Mexico

7 Competitive Landscape
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles

  • 3M Health Care Limited

  • Adherium Limited

  • Amiko Digital Health Limited

  • AsthmaMD

  • AstraZeneca plc

  • Boehringer Ingelheim International GmbH

  • Capsule Technologies Inc.

  • Cohero Health

  • GlaxoSmithKline plc

  • Kaia Health Software GmbH

  • Medical International Research (MIR)

  • Novartis AG

  • NuvoAir

  • Reciprocal Labs (Propeller Health)

  • Sensiron AG

  • Tactio Health

  • Teva Pharmaceuticals Industries Ltd.

8 Investing in North America Market: Risk Assessment and Management
8.1 Risk Evaluation of North America Market
8.2 Critical Success Factors (CSFs)

For more information about this report visit https://www.researchandmarkets.com/r/rcovjm

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900